Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder

Abroad (travel likely)RecruitingPHASE1

Conditions

Healthy Volunteer · Major Depressive Disorder · Depression

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Contact: Study coordinator (NIH Clinical Center Office of Patient Recruitment (OPR) · ccopr@nih.gov · 800-411-1222

Study leads

Carlos A Zarate, M.D.
Principal Investigator
National Institute of Mental Health (NIMH)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Learn How Different Amounts of the Study Medicine Called PF-08103402 Are Tolerated and Act in the Body in Healthy Adults or Adults With Mild To-moderate Asthma

Healthy Volunteer Study · Healthy Adults · Healthy Participants

Abroad (travel likely)RecruitingPHASE1

New Haven, United States

Impact of Exogenous Ketones on Breathing in Healthy Volunteers

Healthy Volunteer

Abroad (travel likely)RecruitingEARLY_PHASE1

Baltimore, United States

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PN-881 in Healthy Subjects.

Healthy Volunteer

Abroad (travel likely)RecruitingPHASE1

Melbourne, Australia

A Study of LY4065967 in Healthy Participants

Healthy

Abroad (travel likely)RecruitingPHASE1

Daytona Beach, United States · Dallas, United States